151 related articles for article (PubMed ID: 26361711)
1. Trends in cannabis-related ambulance presentations from 2000 to 2013 in Melbourne, Australia.
Kaar SJ; Gao CX; Lloyd B; Smith K; Lubman DI
Drug Alcohol Depend; 2015 Oct; 155():24-30. PubMed ID: 26361711
[TBL] [Abstract][Full Text] [Related]
2. Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne.
Lloyd BK; McElwee PR
Drug Alcohol Rev; 2011 May; 30(3):271-80. PubMed ID: 21545557
[TBL] [Abstract][Full Text] [Related]
3. Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia.
Arunogiri S; Moayeri F; Crossin R; Killian JJ; Smith K; Scott D; Lubman DI
Addiction; 2020 Mar; 115(3):473-479. PubMed ID: 31618793
[TBL] [Abstract][Full Text] [Related]
4. Acute harms associated with inhalant misuse: Co-morbidities and trends relative to age and gender among ambulance attendees.
Crossin R; Scott D; Witt KG; Duncan JR; Smith K; Lubman DI
Drug Alcohol Depend; 2018 Sep; 190():46-53. PubMed ID: 29981942
[TBL] [Abstract][Full Text] [Related]
5. Trends in quetiapine use and non-fatal quetiapine-related ambulance attendances.
Heilbronn C; Lloyd B; McElwee P; Eade A; Lubman DI
Drug Alcohol Rev; 2013 Jul; 32(4):405-11. PubMed ID: 23350582
[TBL] [Abstract][Full Text] [Related]
6. The incidence and characteristics of volatile substance use related ambulance attendances in metropolitan Melbourne, Australia.
Cvetkovski S; Dietze P
Soc Sci Med; 2008 Feb; 66(3):776-83. PubMed ID: 18023515
[TBL] [Abstract][Full Text] [Related]
7. Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria.
Dietze PM; Cvetkovski S; Barratt MJ; Clemens S
Med J Aust; 2008 Jun; 188(12):709-11. PubMed ID: 18558893
[TBL] [Abstract][Full Text] [Related]
8. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of oxycodone-related ambulance attendances: analysis of temporal trends and the effect of reformulation in Victoria, Australia from 2013 to 2018.
Nielsen S; Sanfilippo PG; Scott D; Lam T; Smith K; Lubman DI
Addiction; 2021 Aug; 116(8):2233-2241. PubMed ID: 33296537
[TBL] [Abstract][Full Text] [Related]
10. Aggression and violence at ambulance attendances where alcohol, illicit and/or pharmaceutical drugs were recorded: A 5-year study of ambulance records in Victoria, Australia.
Coomber K; Curtis A; Vandenberg B; Miller PG; Heilbronn C; Matthews S; Smith K; Wilson J; Moayeri F; Mayshak R; Lubman DI; Scott D
Drug Alcohol Depend; 2019 Dec; 205():107685. PubMed ID: 31704380
[TBL] [Abstract][Full Text] [Related]
11. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study.
Nielsen S; Crossin R; Middleton M; Martin C; Wilson J; Lam T; Scott D; Smith K; Lubman D
BMJ Open; 2019 May; 9(5):e029170. PubMed ID: 31138584
[TBL] [Abstract][Full Text] [Related]
12. Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.
Nielsen S; Dietze P; Cantwell K; Lee N; Taylor D
J Subst Abuse Treat; 2008 Dec; 35(4):457-61. PubMed ID: 18295435
[TBL] [Abstract][Full Text] [Related]
13. Adverse outcomes of GHB use: Analysis of ambulance attendances in metropolitan and regional Victoria.
Ogeil RP; Faulkner A; Beard N; Killian JJ; Arunogiri S; Phan V; Wilson J; Smith K; Lubman DI; Scott D
Int J Drug Policy; 2023 Jan; 111():103932. PubMed ID: 36527909
[TBL] [Abstract][Full Text] [Related]
14. Recent trends in heroin and pharmaceutical opioid-related harms in Victoria, Australia up to 2018.
Lam T; Kuhn L; Hayman J; Middleton M; Wilson J; Scott D; Lubman DI; Smith K; Nielsen S
Addiction; 2020 Feb; 115(2):261-269. PubMed ID: 31465131
[TBL] [Abstract][Full Text] [Related]
15. The National Ambulance Surveillance System: A novel method for monitoring acute alcohol, illicit and pharmaceutical drug related-harms using coded Australian ambulance clinical records.
Lubman DI; Matthews S; Heilbronn C; Killian JJ; Ogeil RP; Lloyd B; Witt K; Crossin R; Smith K; Bosley E; Carney R; Wilson A; Eastham M; Keene T; Shipp C; Scott D
PLoS One; 2020; 15(1):e0228316. PubMed ID: 32004349
[TBL] [Abstract][Full Text] [Related]
16. The Incidence and Temporal Patterns of Use of Amphetamine-Type Stimulant Use in Traffic-Related Ambulance Attendances From 2015 to 2020 in Victoria, Australia.
Hayley AC; Ogeil RP; Faulkner A; Beard N; Downey LA; Smith K; Lubman DI; Scott D
J Stud Alcohol Drugs; 2023 Jan; 84(1):128-136. PubMed ID: 36799683
[TBL] [Abstract][Full Text] [Related]
17. The effect of heat waves on ambulance attendances in Brisbane, Australia.
Turner LR; Connell D; Tong S
Prehosp Disaster Med; 2013 Oct; 28(5):482-7. PubMed ID: 23981779
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of non-fatal opioid overdoses attended by ambulance services in Australia.
Dietze P; Jolley D; Cvetkovski S; Cantwell K; Jacobs I; Indig D
Aust N Z J Public Health; 2004 Dec; 28(6):569-75. PubMed ID: 15707208
[TBL] [Abstract][Full Text] [Related]
19. The characteristics of acute non-fatal medication-related events attended by ambulance services in the Melbourne Metropolitan Area 1998-2002.
Hutton J; Dent A; Buykx P; Burgess S; Flander L; Dietze P
Drug Alcohol Rev; 2010 Jan; 29(1):53-8. PubMed ID: 20078683
[TBL] [Abstract][Full Text] [Related]
20. Pregabalin misuse-related ambulance attendances in Victoria, 2012-2017: characteristics of patients and attendances.
Crossin R; Scott D; Arunogiri S; Smith K; Dietze PM; Lubman DI
Med J Aust; 2019 Feb; 210(2):75-79. PubMed ID: 30712302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
